Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Shares Issued (2020 - 2025)

Historic Shares Issued for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$1248.8.

  • Molecular Partners Ag's Shares Issued fell 302425.86% to -$1248.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year increase of 5652842.56%. This contributed to the annual value of $19.7 million for FY2024, which is 5630575.98% up from last year.
  • Molecular Partners Ag's Shares Issued amounted to -$1248.8 in Q3 2025, which was down 302425.86% from $1206.7 recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Shares Issued peaked at $57.5 million during Q2 2021, and registered a low of -$57.1 million during Q3 2021.
  • Its 5-year average for Shares Issued is $4.0 million, with a median of $55.3 in 2021.
  • The largest annual percentage gain for Molecular Partners Ag's Shares Issued in the last 5 years was 10922366.39% (2025), contrasted with its biggest fall of 302425.86% (2025).
  • Molecular Partners Ag's Shares Issued (Quarter) stood at $55.8 million in 2021, then plummeted by 99.54% to $259249.0 in 2022, then plummeted by 86.53% to $34915.3 in 2023, then soared by 56597.87% to $19.8 million in 2024, then tumbled by 100.01% to -$1248.8 in 2025.
  • Its Shares Issued was -$1248.8 in Q3 2025, compared to $1206.7 in Q2 2025 and $1.11 in Q1 2025.